| Type | Title | Date Released | |
|---|---|---|---|
6-K | InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement | ||
6-K/A | Private Placement Offering Raises $5.3 Million for Working Capital and Facility Rehabilitation; Shareholder Approval Needed for CEO's Participation. | ||
6-K | InterCure Ltd. Announces $7 Million Private Placement Offering | ||
4 | Cohen Amos (Reporting) | ||
6-K | InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages | ||
D | Form D | ||
6-K | InterCure Ltd. Announces Results of Extraordinary General Meeting of Shareholders | ||
6-K | InterCure Ltd. Announces Voting Procedures for Upcoming Extraordinary General Meeting | ||
6-K/A | InterCure Ltd. Announces Extraordinary General Meeting to Approve 5-to-1 Reverse Share Split | ||
6-K | InterCure Ltd. Announces Extraordinary General Meeting to Approve 5-to-1 Reverse Share Split | ||
6-K | InterCure Secures NIS 22 Million in Private Placement Financing | ||
6-K | InterCure Completes First Tranche of Botanico Acquisition and Initiates U.S. Market Strategic Review |
